01/01/2021
Nefrologie
Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial.
J Am Soc Nephrol 2021; 32: 1474-1483.dr. Van Der Meersch Hansdr. De Vriese AnGeen publicaties gevonden...